aTyr Pharma | LIFE - Umsatzkosten





Umsatzkosten Veränderung Datum
Ardelyx USD 10.85M 6.87M 2025-12
aTyr Pharma USD 3.34M 18.79M 2025-12
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Cipla INR 26.32B 2.79B 2026-03
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 3.54M 1.89M 2025-12
CSL USD 3.87B 2.08B 2025-12
Curis USD 314K 9.96M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Grifols EUR 1.51B 184.45M 2025-12
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Novartis USD 3.46B 83M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
United Therapeutics USD 133.4M 341.3M 2026-03
Xoma 116K 112.7K 2024-06